论文部分内容阅读
目的:探讨用依达拉奉、盐酸法舒地尔联合治疗急性脑梗塞的效果.方法:选取皮山县人民医院2015年收治的确诊为急性脑梗塞的患者260例作为研究对象,设其中单纯用盐酸法舒地尔治疗的患者为对照组(n=130),余下用盐酸法舒地尔联合依达拉奉方案治疗的患者设为观察组(n=130).比较两种治疗方案的治疗效果.结果:疗程结束后根据神经功能缺损程度对两组疗效进行评价,观察组无效19例,对照组无效43例,差异具有统计学意义(P<0.05);两组患者神经功能缺损评分较治疗前均有所降低,且观察组降低更为明显,差异具有统计学意义(P<0.05);随访期间未发现严重不良反应.结论:选用依达拉奉联合盐酸法舒地尔对急性脑梗塞患者进行治疗,能够改善患者病情,疗效确切,值得推广应用.
Objective: To investigate the efficacy of edaravone and fasudil hydrochloride in combination with acute cerebral infarction.Methods: 260 patients diagnosed as acute cerebral infarction admitted by Pishan People’s Hospital in 2015 were selected as research objects, Patients treated with fasudil hydrochloride were controlled (n = 130), and the remaining patients treated with fasudil hydrochloride and edaravone were enrolled as the observation group (n = 130) .Compared with the two treatment regimens Results: After the course of treatment, the curative effect of both groups was evaluated according to the degree of neurological deficit, the observation group was ineffective in 19 cases, the control group was ineffective in 43 cases, the difference was statistically significant (P <0.05); The two groups of patients with neurological deficit score (P <0.05), and no serious adverse reactions were found during the follow-up.Conclusion: The combination of edaravone and fasudil hydrochloride for acute Patients with cerebral infarction treatment, can improve the patient’s condition, the exact effect, it is worth promoting.